FDA Asked To Probe 3M's MRSA Clinical Test Conduct
By Martin Bricketto ( May 11, 2011, 4:27 PM EDT) -- Private equity firm Porton Group said Wednesday that it would ask the U.S. Food and Drug Administration to investigate 3M Co.'s alleged mishandling of clinical trials for a MRSA detection device that harmed marketing plans for the product at an alleged loss to U.K. investors....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.